Price disclosure went too far: Halton

Accelerated and simplified price disclosure measures have created “perverse outcomes”, the program’s architect says  Government policy designed to secure cheap prices for medicines needs to be updated, former Department of Health Secretary, Jane Halton believes.  Speaking during a State of the Industry panel discussion at the Australian Pharmacy Professional conference (APP) on Friday (21 March